• Advisors

    Corporate Headquarters

    Abcam plc
    Discovery Drive
    Cambridge Biomedical Campus
    CB2 0AX
    F: +44 (0)1223 215 215

    Nominated Advisors and Corporate Broker

    J.P. Morgan Cazenove
    25 Bank Street
    Canary Wharf
    London E14 5JP

    Public Relations Advisors

    FTI Consulting
    200 Aldersgate
    Aldersgate Street
    London EC1A 4HD
    F: +44 (0)20 3727 1007

    Joint Corporate Broker

    Numis Securities Limited
    The London Stock Exchange Building,
    10 Paternoster Square, London,
    EC4M 7LT

    Note on Unsolicited phone calls

    We have been made aware of instances where our shareholders have been called regarding their shareholding by persons offering to purchase their shares. This is what is known as a ‘boiler room scam’. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports. If you receive such a call, you are advised not to get into a conversation, note the name of the person and firm contacting you and then end the call.

    Worried about shareholder fraud? Click here for advice from the Financial Conduct Authority

    About Abcam

    Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

    Read more +

    Abcam Products

    As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

    Read more +

    Investor Information

    Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

    Read more +

    Abcam News

    We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

    Read more +